调节性T细胞与B细胞同步缺失是肾移植抗体介导排斥反应的鉴别性免疫特征
该研究用高维流式细胞术在96例肾移植受者中同步追踪调节性T细胞(TREG)与过渡型B细胞,并用体外共培养评估其抑制抗体应答的能力。未发生供者特异性抗体的患者两类细胞持久扩增,而发生供者特异性抗体并进展为抗体介导排斥反应(ABMR)的患者两类细胞显著持续减少。表达T-bet的TREG与过渡型B细胞亚群在ABMR患者中选择性耗竭,其协同缺失与供者特异性抗体应答增强、微血管炎症更广泛及移植物丢失率更高相关。
要点
- TREG与过渡型B细胞均能强效抑制滤泡辅助性T细胞介导的B细胞分化为浆母细胞及抗体生成。
- 未发生供者特异性抗体的肾移植受者中TREG与过渡型B细胞持久扩增。
- ABMR患者中T-bet+CXCR5+TREG与T-bet+CD21-过渡型B细胞协同缺失,伴供者特异性抗体应答增强及移植物丢失率更高。
核心结论
- 研究识别出ABMR患者调节性T细胞与B细胞应答存在协同且持续的缺陷,可能促使其体液免疫调节丧失,并需要及时治疗干预以补充和维持TREG与过渡型B细胞。
研究设计与样本
- 采用高维流式细胞术在96例肾移植受者队列中同步分析并追踪血液中两类主要调节性淋巴细胞:TREG与过渡型B细胞。
- 建立体外共培养实验以评估TREG与过渡型B细胞抑制抗体应答的能力。
主要发现
- TREG与过渡型B细胞均为滤泡辅助性T细胞介导的B细胞向浆母细胞分化及抗体生成的有效抑制者。
- 未发生供者特异性抗体的患者中TREG与过渡型B细胞均持久扩增,而发生供者特异性抗体并进展为ABMR的患者两类细胞显著且持续减少。
- ABMR患者TREG与过渡型B细胞区室中表达转录因子T-bet的特定细胞簇选择性耗竭。
- T-bet+CXCR5+TREG与T-bet+CD21-过渡型B细胞簇的协同缺失与供者特异性抗体应答增强及炎症性、微血管炎症更广泛及肾移植物丢失率更高相关。
临床怎么用
- 作者认为上述发现提示需及时治疗干预以补充和维持此类患者的TREG与过渡型B细胞。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although considerable advances have been made in understanding the cellular effector mechanisms responsible for donor-specific antibody generation leading to antibody-mediated rejection (ABMR), the identification of cellular regulators of such immune responses is lacking. To clarify this, we used high dimensional flow cytometry to concomitantly profile and track the two major subsets of regulatory lymphocytes in blood: T regulatory (TREG) and transitional B cells in a cohort of 96 kidney transplant recipients. Additionally, we established co-culture assays to address their respective capacity to suppress antibody responses in vitro. TREG and transitional B cells were found to be potent suppressors of T follicular helper-mediated B-cell differentiation into plasmablast and antibody generation. TREG and transitional B cells were both durably expanded in patients who did not develop donor-specific antibody post-transplant. However, patients who manifested donor-specific antibody and progressed to ABMR displayed a marked and persistent numerical reduction in TREG and transitional B cells. Strikingly, specific cell clusters expressing the transcription factor T-bet were selectively depleted in both TREG and transitional B-cell compartments in patients with ABMR. Importantly, the coordinated loss of these T-bet+CXCR5+TREG and T-bet+CD21- transitional B-cell clusters was correlated with increased and inflammatory donor specific antibody responses, more extensive microvascular inflammation and a higher rate of kidney allograft loss. Thus, our study identified coordinated and persistent defects in regulatory T- and B-cell responses in patients undergoing ABMR, which may contribute to their loss of humoral immune regulation, and warrant timely therapeutic interventions to replenish and sustain TREG and transitional B cells in these patients.
引用
- Louis K, Fadakar P, Macedo C, et al. Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation. Kidney Int. 2022. PMID: 35090879. doi:10.1016/j.kint.2021.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。